Onconova Therapeutics, Inc. 4
4 · Onconova Therapeutics, Inc. · Filed Jan 28, 2016
Insider Transaction Report
Form 4
BANSAL AJAY
Chief Financial Officer
Transactions
- Award
Stock Option (right to purchase)
2016-01-26+69,984→ 69,984 totalExercise: $0.65Exp: 2026-01-26→ Common Stock (69,984 underlying)
Footnotes (1)
- [F1]These options vest, 25% on January 26, 2016 and 75% on December 31, 2016.